Next Generation Cancer Diagnostics Market 2013 - 2024 Growing Rapidly With Recent Trends, Development, Revenue, Demand And Forecast

 Industry Insights


Global next generation cancer diagnostics market size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to the increasing occurrence of the cancer, second most predominant disease accounting for approximately 8.8 million deaths in 2015 is anticipated to escalate the market for these tests.


Advancements in tests enable early diagnosis and assist efficient detection of different types of tumors which in turn is expected to promote growth over the projected period. The introduction of new products by large bodies, merger, and acquisitions, and joint agreements such as the development of RNA-Seq Kit version by Agilent Technologies Inc. and Agendia Inc. are the factors accountable for the estimated CAGR.


An escalation in the development of companion diagnostics in order to deliver advanced and personalized genomic medicine is also responsible for progress in the coming years.


Furthermore, the technological advancements driving the innovation in point-of-care testing devices is anticipated to aid in commercialization of advanced products thereby supporting revenue generation.


Request a Sample Copy of This Report: https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market/request-sample


Technology Insights


Incorporation of technological advancements such as melting curve examination for identification of mutations, qPCR tools for profiling of tumor in clinical test centers, and gene deletions are accountable for the largest share apprehended by multiplexing and qPCR segment.


With the development of next-generation sequencing technology, the use of traditional methods such as protein and DNA microarrays is expected to decrease through the years. Other factors such as data interpretation tools, growth of supportive library preparation procedures, and technological advancements are accountable for the lucrative adoption of next generation oncology tests among researchers.


Cancer Type Insights


Major categorization for the types of cancer includes cervical, breast, lung, colorectal, and other tumor forms. The other types constitute leukemia, prostate, bladder, brain, skin, uterine, esophageal, Non-Hodgkin lymphoma, ovarian, liver, and thyroid.


In 2015, as per World Health Organization lung cancer was accountable for approximately 1.7 million deaths. Moreover, breast cancer incidence is also estimated to grow thereby escalating the demand for screening and diagnostic technologies.


Application Insights


Growth in the number of research schemes to develop novel products and services which enable primary detection of tumor-causing mutations is expected to affect the advancement in genetic analysis over the forecast period. Biomarker tests offer greater sensitivity in screening and also demonstrate 90% accuracy levels in investigational studies which is attributive to induce progress in the coming years.


Function Insights


Risk analysis, prognostic based diagnosis, tumor screening, therapeutic monitoring, & theranostics are the different functions of next generation oncology diagnostic tests.


The prognostic diagnostics segment is anticipated to witness the fastest growth in the coming years as a consequence of higher adoption of prognosis which plays important role in designing oncology therapies and protocols for chemotherapy, radiation-based treatment, and gene therapy.


Regional Insights


The next generation cancer diagnostics market is dominated by North America with approximately 40% market share. Favorable government initiatives such as launch of “80% by 2018” program for detection of colon cancer is anticipated to propel progress in the coming years.


In this program, almost 170 groups including medical professional societies, health departments, government health departments, and cancer coalitions are functioning to accomplish the mutual goal of attaining 80% screening for oncology diseases by 2018 and are working forward to eliminate the oncology disorders.


Asia Pacific is anticipated to be the fastest developing region. Factors such as economic augmentation, higher investments, and greater untapped market are accountable for the fastest growth of resign in diagnosis sector.


Competitive Insights


Major entities functioning in the market include Novartis AG, Myriad Genetics Inc., Illumina Inc., Almac Group, Sysmex Corporation, F. Hoffmann-La Roche Ltd, Agilent Technologies, Genomic Health, Almac Group, Koninklijke Philips N.V, and Cepheid.


Market players by offering clinical analysis amenities are implementing geographic expansion strategies. Furthermore, reimbursement coverage plays an important factor to increase the patient convenience to the precision drug. For example, in October 2015, U.S., Medicare started the reimbursement procedure for a prostate tumor type known as Oncotype DX.


Browse Full Research Report with TOC: https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market


Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person: 

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com


Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com


Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Comments

Post a Comment

Popular posts from this blog

TV and Radio Subscription Market Landscape and its Growth Prospects over the coming years from 2017-2021

TV subscription is the service that is delivered (on paying a subscription fee) to the viewer using a cable or over the air. Video and voice services, games, movies, and contents from various demographics are some of the most popular services offered by the TV operators. Request a Sample Copy of This Report:   https://www.radiantinsights.com/research/global-tv-and-radio-subscription-market-2017-2021/request-sample Covered in this report The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: APAC EMEA The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors Bell Media CBS Comcast Cox Communications DISH Network Pandora Radio Sky Other prominent vendors ABC Radio Altice USA America Movil AT&am
Read more

Global Online Takeaway Food Market Size and Analysis by Trend, Regions 2018

23-oct-2018 Global Online Takeaway Food Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Online Takeaway Food is a process of ordering food from food cooperative or restaurant via an online application or web page. Rising working people populace, expansion of internet penetration for ordering food online, growing urbanization, rapid access to mobile phones, and rising disposable income are documented as major factors of Online Takeaway Food Market that are estimated to enhance the growth in the years to come. However, growing obese populace, low in nutrition, and rising importance of healthy health among customers are the factors that may restrain overall market in the coming years. Online Takeaway Food Market is segmented based on type, product type, application, and region. Mobile apps, restaurant-controlled, independent, and other types could be explored in Online Takeaway Food in t
Read more

U.S. E-cigarette And Vape Market size is expected to reach USD 18.5 billion by 2025

Image
7-aug-19 The U.S. e-cigarette and vape market exhibiting a CAGR of 24.1% from 2019 to 2025, according to a new study conducted. The ability of e-cigarettes to reduce exposure to potentially toxic substances is expected to drive the market over the forecast period. Another factor that is expected to drive the market is that health hazards associated with electronic smoking and vaping devices are relatively lower as compared to conventional tobacco cigarettes. Changing lifestyle and preferences of adult smokers bodes well for the U.S. market. Adult smokers who are addicted to smoking but are willing to quit the habit are shifting from conventional tobacco cigarettes to electronic variants, thereby driving the adoption of the latter over the forecast period. Electronic smoking devices and products claim to minimize the risk of cancer usually posed by conventional cigarettes. Moreover, vaping devices do not have any smoke associated with them, which means, they pose fewer health r
Read more